Cynata Therapeutics Limited
CYYNF
$0.118
$0.01615.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | 28.68% | -0.20% | -15.63% | 0.48% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -2.84% | -0.87% | 0.00% | 1.09% | -0.65% |
| Total Other Non-Cash Items | -2.74% | -12.37% | 0.22% | 252.21% | 0.47% |
| Change in Net Operating Assets | -- | -- | -0.21% | -- | -- |
| Cash from Operations | 2.75% | 41.76% | -0.21% | -6.21% | 0.47% |
| Capital Expenditure | 2.98% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.98% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Financing | -2.75% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 2.81% | -248.02% | 0.21% | 199.79% | 0.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.75% | 188.17% | -0.20% | -0.14% | 0.48% |